Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A Review on Dapsone Hypersensitivity Syndrome Among Chinese Patients with an Emphasis on Preventing Adverse Drug Reactions with Genetic Testing.

The American journal of tropical medicine and hygiene - 1 May 2017

Wang Na, Parimi Leela, Liu Hong, Zhang Furen

Abstract excerpt

AbstractDapsone is a bactericidal and bacteriostatic against Mycobacterium leprae, a causative agent of leprosy. Dapsone is also applied in a range of medical fields because of its anti-inflammatory and immunomodulatory effects. Dapsone hypersensitivity syndrome (DHS) is a rare yet serious adverse drug reaction (ADR) caused by dapsone involving multiple organs. We performed a systematic review of published...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Dapsone
Share to Drug Hypersensitivity

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Drug Substitution

Share to Leprosy

Share to Mycobacterium leprae

Share to Primary Prevention

Share to Survival Analysis

Share to Syndrome

Source

Open in PubMed Open full text

Identifiers

PMID: 28167593
DOI: 10.4269/ajtmh.16-0628
PMCID: PMC5417189

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A Review on Dapsone Hypersensitivity Syndrome Among Chinese Patients with an Emphasis on Preventing Adverse Drug Reactions with Genetic Testing.PMID 28167593Read ↗

HLA-B*13:01 and the dapsone hypersensitivity syndrome.Semantic proximity Read ↗

Validation Study of HLA-B*13:01 as a Biomarker of Dapsone Hypersensitivity Syndrome in Leprosy Patients in IndonesiaSemantic proximity Read ↗

Validation study of HLA-B*13:01 as a biomarker of dapsone hypersensitivity syndrome in leprosy patients in Indonesia.Semantic proximity Read ↗

Association Between HLA-B*1301 and Dapsone-Induced Cutaneous Adverse Drug Reactions: A Systematic Review and Meta-analysis.Semantic proximity Read ↗

Update on the Genetic Basis of Drug Hypersensitivity Reactions.Semantic proximity Read ↗

Amino Acid Variants of HLA-DRB1 Confer Susceptibility to Dapsone Hypersensitivity Syndrome in Addition to HLA-B*13:01.Semantic proximity Read ↗

An Updated Review of the Molecular Mechanisms in Drug Hypersensitivity.Semantic proximity Read ↗

The Function of HLA-B*13:01 Involved in the Pathomechanism of Dapsone-Induced Severe Cutaneous Adverse Reactions.Semantic proximity Read ↗

Generation and characterization of dapsone- and nitroso-dapsone-specific T-cells : an insight into the molecular pathomechanism of dapsone hypersensitivity syndromeSemantic proximity Read ↗

Genetic associations of human leukocyte antigen alleles in cutaneous delayed drug hypersensitivity reactions: An updated reviewSemantic proximity Read ↗

HLA-B*13 :01 Is a Predictive Marker of Dapsone-Induced Severe Cutaneous Adverse Reactions in Thai Patients.Semantic proximity Read ↗

Pharmacogenetics of cutaneous adverse drug reactionsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.